These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35771366)

  • 61. Induction Chemotherapy and Chemoradiotherapy Combined to ASA vs. Placebo for High-Risk Rectal Cancer: Results of a Randomized Trial.
    Ominelli J; Araujo ROC; Valadão M; Padoan MLA; Lopes Dos Santos VM; Dutra JG; Torres CC; Barbosa MA; Guimarães R; Carvalho JCC; Ferreira MA; de Oliveira IM; Small I; de Melo AC; Araujo LH
    Clin Colorectal Cancer; 2022 Sep; 21(3):e196-e204. PubMed ID: 35668002
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Predictive Value of Pre-/Postneoadjuvant Chemoradiotherapy MRI Characteristics for Patient Outcomes in Locally Advanced Rectal Cancer.
    Meng Y; Wan L; Zhang C; Wang C; Ye F; Li S; Zou S; Cheng J; Xu K; Zhou C; Zhang H
    Acad Radiol; 2020 Sep; 27(9):e233-e243. PubMed ID: 31780392
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Poor response at restaging MRI and high incomplete resection rates of locally advanced mucinous rectal cancer after chemoradiation therapy.
    Koëter T; Stijns RCH; van Koeverden S; Hugen N; van der Heijden JAG; Nederend J; van Zwam PH; Nagtegaal ID; Verheij M; Rutten HJT; de Wilt JHW
    Colorectal Dis; 2021 Sep; 23(9):2341-2347. PubMed ID: 34051043
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
    Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
    Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer.
    Seierstad T; Hole KH; Grøholt KK; Dueland S; Ree AH; Flatmark K; Redalen KR
    Br J Radiol; 2015 Jul; 88(1051):20150097. PubMed ID: 25899892
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Improved response rate in patients with prognostically poor locally advanced rectal cancer after treatment with induction chemotherapy and chemoradiotherapy when compared with chemoradiotherapy alone: A matched case-control study.
    Voogt ELK; Schaap DP; van den Berg K; Nieuwenhuijzen GAP; Bloemen JG; Creemers GJ; Willems J; Cnossen JS; Peulen HMU; Nederend J; van Lijnschoten G; Burger JWA; Rutten HJT
    Eur J Surg Oncol; 2021 Sep; 47(9):2429-2435. PubMed ID: 34030921
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
    Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
    World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment.
    Aker M; Boone D; Chandramohan A; Sizer B; Motson R; Arulampalam T
    Abdom Radiol (NY); 2018 Dec; 43(12):3213-3219. PubMed ID: 29767284
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MRI features and texture analysis for the early prediction of therapeutic response to neoadjuvant chemoradiotherapy and tumor recurrence of locally advanced rectal cancer.
    Park H; Kim KA; Jung JH; Rhie J; Choi SY
    Eur Radiol; 2020 Aug; 30(8):4201-4211. PubMed ID: 32270317
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MAGNETIC RESONANCE IMAGING TO EVALUATE NEOADJUVANT THERAPY EFFECTS ON RECTAL CARCINOMA.
    Sofić A; Vukobrat-Bijedić Z; Husić-Selimović A; Šehović N; Buija D; Eminagić D; Banjin M; Đuran A
    Acta Clin Croat; 2015 Sep; 54(3):303-8. PubMed ID: 26666099
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Can Endorectal Ultrasound, MRI, and Mucosa Integrity Accurately Predict the Complete Response for Mid-Low Rectal Cancer After Preoperative Chemoradiation? A Prospective Observational Study from a Single Medical Center.
    Liu S; Zhong GX; Zhou WX; Xue HD; Pan WD; Xu L; Lu JY; Wu B; Lin GL; Qiu HZ; Xiao Y
    Dis Colon Rectum; 2018 Aug; 61(8):903-910. PubMed ID: 29944579
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI.
    Zou HH; Yu J; Wei Y; Wu JF; Xu Q
    J Magn Reson Imaging; 2019 Mar; 49(3):885-893. PubMed ID: 30079601
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
    Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
    Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Value of percent change in tumoral volume measured at T
    Quaia E; Gennari AG; Ricciardi MC; Ulcigrai V; Angileri R; Cova MA
    J Magn Reson Imaging; 2016 Dec; 44(6):1415-1424. PubMed ID: 27219471
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Magnetic resonance tumour regression grade and pathological correlates in patients with rectal cancer.
    Jang JK; Lee JL; Park SH; Park HJ; Park IJ; Kim JH; Choi SH; Kim J; Yu CS; Kim JC
    Br J Surg; 2018 Nov; 105(12):1671-1679. PubMed ID: 29893988
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience.
    Patel UB; Taylor F; Blomqvist L; George C; Evans H; Tekkis P; Quirke P; Sebag-Montefiore D; Moran B; Heald R; Guthrie A; Bees N; Swift I; Pennert K; Brown G
    J Clin Oncol; 2011 Oct; 29(28):3753-60. PubMed ID: 21876084
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy.
    Delli Pizzi A; Cianci R; Genovesi D; Esposito G; Timpani M; Tavoletta A; Pulsone P; Basilico R; Gabrielli D; Rosa C; Caravatta L; Di Tommaso M; Caulo M; Filippone A
    Abdom Radiol (NY); 2018 Sep; 43(9):2221-2230. PubMed ID: 29332248
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dynamic Contrast-enhanced Magnetic Resonance Imaging Evaluation of Whole Tumour Perfusion Heterogeneity Predicts Distant Disease-free Survival in Locally Advanced Rectal Cancer.
    Pham TT; Wong K; Liney G; Lim S; Graham PL; Borok N; Truong MX; Rai R; Henderson C; Lee M; Barton MB
    Clin Oncol (R Coll Radiol); 2022 Sep; 34(9):561-570. PubMed ID: 35738953
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.
    Shaish H; Aukerman A; Vanguri R; Spinelli A; Armenta P; Jambawalikar S; Makkar J; Bentley-Hibbert S; Del Portillo A; Kiran R; Monti L; Bonifacio C; Kirienko M; Gardner KL; Schwartz L; Keller D
    Eur Radiol; 2020 Nov; 30(11):6263-6273. PubMed ID: 32500192
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Timing of surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer - A comparison of magnetic resonance imaging at two time points and histopathological responses.
    West MA; Dimitrov BD; Moyses HE; Kemp GJ; Loughney L; White D; Grocott MP; Jack S; Brown G
    Eur J Surg Oncol; 2016 Sep; 42(9):1350-8. PubMed ID: 27160356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.